Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Biopharmaceuticals Contract Manufacturing Global Market Report 2024
... Operations; Analytical And QC studies; Packaging4) By Application: Clinical; CommercialCovering: Boehringer Ingelheim GmbH; Lonza Group Ltd.; Inno Biologics Sdn Bhd; Rentschler Biopharma SE; Samsung Biologics Co. Ltd. Biopharmaceuticals Contract Manufacturing Global Market Report 2024 from ... Read More
-
Insulin biosimilars Global Market Report 2024
... Retail Pharmacies; Online Pharmacies4) By End User: Hospitals; Ambulatory Surgical CentersCovering: Eli Lilly and Company; Boehringer Ingelheim GmbH; Merck & Co Inc.; Pfizer Inc.; Biocon Ltd. Insulin biosimilars Global Market Report 2024 from The Business ... Read More
-
Small-Scale Bioreactors Global Market Report 2024
... Stem Cells; Recombinant Proteins; Vaccines; Gene Therapy4) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs); Academic And Research InstitutesCovering: Sartorius AG; Thermo Fisher Scientific Inc.; Merck KGaA; ... Read More
-
Biobetters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Biobetters Market has demonstrated robust growth from 2024 to 2031. This growth trajectory is set to continue, with an anticipated steady CAGR of 10% expected between 2024 and 2031. In 2024, the global Biobetters Market ... Read More
-
Global Insulin Biosimilars Market - 2023-2030
... period 2023-2030. Biosimilars are equivalent to a reference biologic drug and are developed after the patent on the concerned biologic drug has passed. Biosimilar insulin is a biological replica of an actual insulin and there ... Read More
-
Cell Harvesting Market by Type (Automated Cell Harvesters, Manual Cell Harvesters), Application (Biopharmaceutical, Stem Cell Research) - Global Forecast 2024-2030
... to reach USD 2.34 billion in 2024, at a CAGR 8.96% to reach USD 3.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Harvesting Market. It offers ... Read More
-
Oncology Biosimilars Market by Application (Cancer Treatment Drugs, Supportive Care Drugs), End-User (Hospitals, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 5.48 billion in 2024, at a CAGR 18.11% to reach USD 14.91 billion by 2030. Global Oncology Biosimilars Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Oncology Biosimilars ... Read More
-
Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.48 billion in 2024, at a CAGR 9.49% to reach USD 28.49 billion by 2030. Global Biopharmaceutical Bioseparation Systems Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 621.39 million in 2024, at a CAGR 11.71% to reach USD 1,213.54 million by 2030. Global Biopharmaceuticals Manufacturing Consumables Testing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Global Forecast 2024-2030
... USD 81.32 billion in 2023 and expected to reach USD 95.65 billion in 2024, at a CAGR 18.10% to reach USD 260.65 billion by 2030. Global Biopharmaceutical CMO & CRO Market FPNV Positioning Matrix The ... Read More
-
Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 16.86 billion in 2024, at a CAGR 7.82% to reach USD 26.52 billion by 2030. Global Biopharmaceutical Fermentation System Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Drug Discovery Technologies Market by Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Drug Type (Biologic Drugs, Small-molecule Drugs), End User - Global Forecast 2024-2030
... 2023 and expected to reach USD 71.32 billion in 2024, at a CAGR 10.64% to reach USD 131.08 billion by 2030. Drug discovery consists of new medications being discovered by using a vast array of ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Global Forecast 2024-2030
... and expected to reach USD 1.59 billion in 2024, at a CAGR 5.61% to reach USD 2.21 billion by 2030. Global Pompe Disease Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell Banking, Diagnostics) - Global Forecast 2024-2030
... 33.05 billion in 2024, at a CAGR 15.36% to reach USD 77.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment ... Read More
-
Systemic Lupus Erythematosus Market by Drug Type (Antimalarial Drugs, B-Cell Modulators, Biologics), Mode of Delivery (Intravenous, Oral, Subcutaneous) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.24 billion in 2024, at a CAGR 10.54% to reach USD 4.12 billion by 2030. Global Systemic Lupus Erythematosus Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Cell Culture Media Market by Product Type (Chemically Defined Media, Classical Media, Lysogeny Broth), Application (Biological Drug Discovery, Biopharmaceuticals, Cancer Research), End-User - Global Forecast 2024-2030
... USD 1.42 billion in 2023 and expected to reach USD 1.61 billion in 2024, at a CAGR 13.53% to reach USD 3.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Ulcerative Colitis Market by Drug (Anti-Inflammatory Drugs, Anti-TNF Biologics, Calcineurin Inhibitors), Disease (Fulminant Colitis, Left-Sided Colitis, Pancolitis or Universal Colitis), Route of Administration - Global Forecast 2024-2030
... USD 7.45 billion in 2023 and expected to reach USD 8.14 billion in 2024, at a CAGR 9.41% to reach USD 13.99 billion by 2030. Global Ulcerative Colitis Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2024-2030
... USD 10.70 billion in 2023 and expected to reach USD 12.09 billion in 2024, at a CAGR 13.54% to reach USD 26.03 billion by 2030. Global Upstream Bioprocessing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion), End-user - Global Forecast 2024-2030
... expected to reach USD 3.15 billion in 2024, at a CAGR 5.24% to reach USD 4.30 billion by 2030. Global Spine Biologics MarketSpine biologics refer to a category of medical products and treatments that utilize ... Read More
-
Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Global Forecast 2024-2030
... 6.54 billion in 2023 and expected to reach USD 7.30 billion in 2024, at a CAGR 11.79% to reach USD 14.28 billion by 2030. Global Biologics Contract Development Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030
... at USD 9.88 billion in 2023 and expected to reach USD 10.59 billion in 2024, at a CAGR 7.44% to reach USD 16.35 billion by 2030. Global Biologics Contract Development & Manufacturing Organization MarketBiologics contract ... Read More
-
Life Sciences BPO Market by Services (Contract Sales & Marketing Outsourcing, Medical Devices Outsourcing, Pharmaceutical Outsourcing), Application (Medical Devices, Pharmaceutical & Biopharmaceuticals) - Global Forecast 2024-2030
... USD 387.64 billion in 2023 and expected to reach USD 423.92 billion in 2024, at a CAGR 9.49% to reach USD 731.43 billion by 2030. Global Life Sciences BPO Market FPNV Positioning Matrix The FPNV ... Read More
-
Biotechnology Instrumentation Market by Product (Bioreactors, Centrifuges, Electrophoresis), End-User (Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), Government & Academic Institutes) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 26.49 billion in 2024, at a CAGR 9.84% to reach USD 46.67 billion by 2030. Global Biotechnology Instrumentation Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
Research Assistance
